Enhanced Metabolite Productivity of Escherichia coli Adapted to Glucose M9 Minimal Medium

High productivity of biotechnological strains is important to industrial fermentation processes and can be constrained by precursor availability and substrate uptake rate. Adaptive laboratory evolution (ALE) of MG1655 to glucose minimal M9 medium has been shown to increase strain fitness, mainly thr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in bioengineering and biotechnology 2018-11, Vol.6, p.166-166
Hauptverfasser: Rugbjerg, Peter, Feist, Adam M, Sommer, Morten Otto Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:High productivity of biotechnological strains is important to industrial fermentation processes and can be constrained by precursor availability and substrate uptake rate. Adaptive laboratory evolution (ALE) of MG1655 to glucose minimal M9 medium has been shown to increase strain fitness, mainly through a key mutation in the transcriptional regulator , which increases flux through central carbon metabolism and the glucose uptake rate. We wanted to test the hypothesis that a substrate uptake enhancing mutation can translate to increased productivity in a strain possessing a heterologous metabolite pathway. When engineered for heterologous mevalonate production, we found that E672K strains displayed 114-167% higher glucose uptake rates and 48-77% higher mevalonate productivities in glucose minimal M9 medium. This improvement in heterologous mevalonate productivity of the E672K strain is likely mediated by the elevated glucose uptake rate of such strains, which favors overflow metabolism toward acetate production and availability of acetyl-CoA as precursor. These results demonstrate the utility of adaptive laboratory evolution (ALE) to generate a platform strain for an increased production rate for a heterologous product.
ISSN:2296-4185
2296-4185
DOI:10.3389/fbioe.2018.00166